AG真人官方

STOCK TITAN
  1. Home
  2. Sec-filings
  3. CME
  4. [Form 4] CME Group Inc. Insider Trading Activity

[Form 4] CME Group Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

CME Group director Timothy S. Bitsberger reported an insider transaction on Form 4 filed June 28, 2025, disclosing activity from June 25, 2025. Key details:

  • Acquired 532 shares of Class A Common Stock at $273.03 per share
  • Shares were granted through the CME Group Director Stock Plan
  • Following the transaction, Bitsberger directly owns 11,121 shares

This transaction represents a standard director stock grant as part of CME Group's board compensation program. The filing was signed by Jenelle Chalmers on behalf of Bitsberger on June 26, 2025. No derivative securities were involved in this transaction.

Il direttore di CME Group, Timothy S. Bitsberger, ha comunicato una transazione interna tramite il Modulo 4 depositato il 28 giugno 2025, riferendo un'attivit脿 del 25 giugno 2025. Dettagli principali:

  • Acquisto di 532 azioni di Azioni Ordinarie Classe A a 273,03 $ per azione
  • Le azioni sono state assegnate tramite il Piano Azionario per Direttori di CME Group
  • Dopo la transazione, Bitsberger possiede direttamente 11.121 azioni

Questa operazione rappresenta una normale assegnazione di azioni per direttori nell'ambito del programma di compensazione del consiglio di amministrazione di CME Group. Il modulo 猫 stato firmato da Jenelle Chalmers per conto di Bitsberger il 26 giugno 2025. Nessun titolo derivato 猫 stato coinvolto in questa operazione.

El director de CME Group, Timothy S. Bitsberger, inform贸 una transacci贸n interna en el Formulario 4 presentado el 28 de junio de 2025, revelando una actividad del 25 de junio de 2025. Detalles clave:

  • Adquisici贸n de 532 acciones de acciones ordinarias Clase A a $273.03 por acci贸n
  • Las acciones fueron otorgadas a trav茅s del Plan de Acciones para Directores de CME Group
  • Tras la transacci贸n, Bitsberger posee directamente 11,121 acciones

Esta transacci贸n representa una concesi贸n est谩ndar de acciones para directores como parte del programa de compensaci贸n del consejo de CME Group. El formulario fue firmado por Jenelle Chalmers en nombre de Bitsberger el 26 de junio de 2025. No se involucraron valores derivados en esta transacci贸n.

CME 攴鸽９ 鞚挫偓 Timothy S. Bitsberger電� 2025雲� 6鞗� 28鞚� 鞝滌稖霅� Form 4鞐愳劀 2025雲� 6鞗� 25鞚检潣 雮措秬 瓯半灅毳� 氤搓碃頄堨姷雼堧嫟. 欤检殧 雮挫毄鞚� 雼れ潓瓿� 臧欖姷雼堧嫟:

  • 韥措灅鞀� A 氤错喌欤� 532欤�毳� 欤茧嫻 $273.03鞐� 旆摑
  • 欤检嫕鞚� CME 攴鸽９ 鞚挫偓 欤检嫕 瓿勴殟鞚� 韱淀暣 攵�鞐惃
  • 瓯半灅 頉� Bitsberger電� 歆侅爲 11,121欤�毳� 氤挫湢

鞚� 瓯半灅電� CME 攴鸽９ 鞚挫偓須� 氤挫儊 頂勲攴鸽灗鞚� 鞚柬櫂鞙茧 鞚措（鞏挫 響滌 鞚挫偓 欤检嫕 攵�鞐瀰雼堧嫟. 頃措嫻 靹滊電� 2025雲� 6鞗� 26鞚� Jenelle Chalmers臧� Bitsberger毳� 雽�鞁犿暣 靹滊獏頄堨姷雼堧嫟. 鞚� 瓯半灅鞐愲姅 韺岇儩 歃濌秾鞚� 韽暔霅橃 鞎婌晿鞀惦媹雼�.

Le directeur du groupe CME, Timothy S. Bitsberger, a d茅clar茅 une transaction d'initi茅 via le formulaire 4 d茅pos茅 le 28 juin 2025, r茅v茅lant une activit茅 du 25 juin 2025. D茅tails cl茅s :

  • Acquisition de 532 actions ordinaires de classe A au prix de 273,03 $ par action
  • Les actions ont 茅t茅 attribu茅es dans le cadre du plan d'actions pour les administrateurs de CME Group
  • Suite 脿 cette transaction, Bitsberger d茅tient directement 11 121 actions

Cette op茅ration correspond 脿 une attribution standard d'actions aux administrateurs dans le cadre du programme de r茅mun茅ration du conseil d'administration de CME Group. Le formulaire a 茅t茅 sign茅 par Jenelle Chalmers au nom de Bitsberger le 26 juin 2025. Aucun titre d茅riv茅 n'a 茅t茅 impliqu茅 dans cette transaction.

CME Group-Direktor Timothy S. Bitsberger meldete eine Insider-Transaktion im Formular 4, das am 28. Juni 2025 eingereicht wurde und Aktivit盲ten vom 25. Juni 2025 offenlegt. Wichtige Details:

  • Erwerb von 532 Aktien der Klasse A Stammaktien zu je 273,03 $
  • Die Aktien wurden 眉ber den CME Group Director Stock Plan zugeteilt
  • Nach der Transaktion besitzt Bitsberger direkt 11.121 Aktien

Diese Transaktion stellt eine 眉bliche Aktienzuteilung f眉r Direktoren im Rahmen des Verg眉tungsprogramms des Vorstands von CME Group dar. Die Einreichung wurde am 26. Juni 2025 von Jenelle Chalmers im Auftrag von Bitsberger unterzeichnet. Es waren keine Derivate an dieser Transaktion beteiligt.

Positive
  • None.
Negative
  • None.

Il direttore di CME Group, Timothy S. Bitsberger, ha comunicato una transazione interna tramite il Modulo 4 depositato il 28 giugno 2025, riferendo un'attivit脿 del 25 giugno 2025. Dettagli principali:

  • Acquisto di 532 azioni di Azioni Ordinarie Classe A a 273,03 $ per azione
  • Le azioni sono state assegnate tramite il Piano Azionario per Direttori di CME Group
  • Dopo la transazione, Bitsberger possiede direttamente 11.121 azioni

Questa operazione rappresenta una normale assegnazione di azioni per direttori nell'ambito del programma di compensazione del consiglio di amministrazione di CME Group. Il modulo 猫 stato firmato da Jenelle Chalmers per conto di Bitsberger il 26 giugno 2025. Nessun titolo derivato 猫 stato coinvolto in questa operazione.

El director de CME Group, Timothy S. Bitsberger, inform贸 una transacci贸n interna en el Formulario 4 presentado el 28 de junio de 2025, revelando una actividad del 25 de junio de 2025. Detalles clave:

  • Adquisici贸n de 532 acciones de acciones ordinarias Clase A a $273.03 por acci贸n
  • Las acciones fueron otorgadas a trav茅s del Plan de Acciones para Directores de CME Group
  • Tras la transacci贸n, Bitsberger posee directamente 11,121 acciones

Esta transacci贸n representa una concesi贸n est谩ndar de acciones para directores como parte del programa de compensaci贸n del consejo de CME Group. El formulario fue firmado por Jenelle Chalmers en nombre de Bitsberger el 26 de junio de 2025. No se involucraron valores derivados en esta transacci贸n.

CME 攴鸽９ 鞚挫偓 Timothy S. Bitsberger電� 2025雲� 6鞗� 28鞚� 鞝滌稖霅� Form 4鞐愳劀 2025雲� 6鞗� 25鞚检潣 雮措秬 瓯半灅毳� 氤搓碃頄堨姷雼堧嫟. 欤检殧 雮挫毄鞚� 雼れ潓瓿� 臧欖姷雼堧嫟:

  • 韥措灅鞀� A 氤错喌欤� 532欤�毳� 欤茧嫻 $273.03鞐� 旆摑
  • 欤检嫕鞚� CME 攴鸽９ 鞚挫偓 欤检嫕 瓿勴殟鞚� 韱淀暣 攵�鞐惃
  • 瓯半灅 頉� Bitsberger電� 歆侅爲 11,121欤�毳� 氤挫湢

鞚� 瓯半灅電� CME 攴鸽９ 鞚挫偓須� 氤挫儊 頂勲攴鸽灗鞚� 鞚柬櫂鞙茧 鞚措（鞏挫 響滌 鞚挫偓 欤检嫕 攵�鞐瀰雼堧嫟. 頃措嫻 靹滊電� 2025雲� 6鞗� 26鞚� Jenelle Chalmers臧� Bitsberger毳� 雽�鞁犿暣 靹滊獏頄堨姷雼堧嫟. 鞚� 瓯半灅鞐愲姅 韺岇儩 歃濌秾鞚� 韽暔霅橃 鞎婌晿鞀惦媹雼�.

Le directeur du groupe CME, Timothy S. Bitsberger, a d茅clar茅 une transaction d'initi茅 via le formulaire 4 d茅pos茅 le 28 juin 2025, r茅v茅lant une activit茅 du 25 juin 2025. D茅tails cl茅s :

  • Acquisition de 532 actions ordinaires de classe A au prix de 273,03 $ par action
  • Les actions ont 茅t茅 attribu茅es dans le cadre du plan d'actions pour les administrateurs de CME Group
  • Suite 脿 cette transaction, Bitsberger d茅tient directement 11 121 actions

Cette op茅ration correspond 脿 une attribution standard d'actions aux administrateurs dans le cadre du programme de r茅mun茅ration du conseil d'administration de CME Group. Le formulaire a 茅t茅 sign茅 par Jenelle Chalmers au nom de Bitsberger le 26 juin 2025. Aucun titre d茅riv茅 n'a 茅t茅 impliqu茅 dans cette transaction.

CME Group-Direktor Timothy S. Bitsberger meldete eine Insider-Transaktion im Formular 4, das am 28. Juni 2025 eingereicht wurde und Aktivit盲ten vom 25. Juni 2025 offenlegt. Wichtige Details:

  • Erwerb von 532 Aktien der Klasse A Stammaktien zu je 273,03 $
  • Die Aktien wurden 眉ber den CME Group Director Stock Plan zugeteilt
  • Nach der Transaktion besitzt Bitsberger direkt 11.121 Aktien

Diese Transaktion stellt eine 眉bliche Aktienzuteilung f眉r Direktoren im Rahmen des Verg眉tungsprogramms des Vorstands von CME Group dar. Die Einreichung wurde am 26. Juni 2025 von Jenelle Chalmers im Auftrag von Bitsberger unterzeichnet. Es waren keine Derivate an dieser Transaktion beteiligt.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Bitsberger Timothy S.
(Last) (First) (Middle)
20 S. WACKER DRIVE
(Street)
CHICAGO IL 60606
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
CME GROUP INC. [ CME ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
06/25/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock Class A 06/25/2025 A(1) 532 A $273.03 11,121 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Granted pursuant to the CME Group Director Stock Plan, as amended and restated.
Remarks:
By: Jenelle Chalmers For: Timothy S. Bitsberger 06/26/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source:

FAQ

How many CME Group shares did Director Timothy Bitsberger acquire on June 25, 2025?

According to the Form 4 filing, Director Timothy Bitsberger acquired 532 shares of CME Group Class A Common Stock on June 25, 2025, at a price of $273.03 per share.

What is Timothy Bitsberger's total CME stock ownership after the June 2025 transaction?

Following the reported transaction, Timothy Bitsberger beneficially owned 11,121 shares of CME Group Class A Common Stock directly (Form: D).

What was the nature of CME director Bitsberger's stock acquisition in June 2025?

The shares were granted pursuant to the CME Group Director Stock Plan, as amended and restated, as indicated in the footnotes of the Form 4 filing.

Who filed the Form 4 for CME Group director Timothy Bitsberger?

The Form 4 was filed by Jenelle Chalmers on behalf of Timothy S. Bitsberger on June 26, 2025, one day after the transaction date.

Does Timothy Bitsberger own any derivative securities of CME Group?

The Form 4 filing shows no derivative securities (such as options, warrants, or convertible securities) were reported in Table II, indicating no derivative holdings were involved in this transaction.
Stock CME logo
CME Group

NASDAQ:CME

CME Rankings

#183 Ranked by Market Cap
#1469 Ranked by Dividends

CME Latest News

Jul 23, 2025
CME Group Inc. Reports All-Time Record Revenue, Adjusted Operating Income, Adjusted Net Income and Adjusted Earnings Per Share for Q2 2025
Jul 22, 2025
CME Group and Nasdaq Extend Exclusive Nasdaq-100 Futures License Through 2039
Jul 10, 2025
CME Group International Average Daily Volume Hits Record 9.2 Million Contracts in Q2 2025, Up 18% Year over Year
Jul 2, 2025
CME Group Completes First Delivery Cycle of Hard Red Spring Wheat Futures
Jul 2, 2025
CME Group Sets Record Quarterly and June ADV, Driven by Growth Across Asset Classes

CME Latest SEC Filings

Jul 23, 2025
[8-K] CME Group Inc. Reports Material Event
Jun 26, 2025
[Form 4] CME Group Inc. Insider Trading Activity
Jun 26, 2025
[Form 4] CME Group Inc. Insider Trading Activity
Jun 26, 2025
[Form 4] CME Group Inc. Insider Trading Activity
Jun 26, 2025
[Form 4] CME Group Inc. Insider Trading Activity

CME Stock Data

98.97B
358.67M
0.46%
89.89%
1.4%
Financial Data & Stock Exchanges
Security & Commodity Brokers, Dealers, Exchanges & Services
United States
CHICAGO